FAC Explorer

Aspira INC of Illinois

Audits
5
Findings
21
Total Expended
$19.95M
Latest Accepted
2025-10-09
Location: Chicago, IL
UEI: PEKAEBFQNNZ3 EIN: 362666800

SAM.gov Exclusion Status:

Audits by Year

  • 2022 1
  • 2023 2
  • 2024 2

Top Programs

By expenditures

Contacts

Name Title Type
Jose Reyes Chief Operating Officer Auditee
Andrew Lotts Partner Auditee
Samuel Perez CFO Auditee
Chad Porter Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
370624 2024 2025-10-09 Krd LTD $4.49M
367157 2023 2025-09-23 Cjbs LLC $4.17M
339073 2024 2025-01-21 Krd LTD $4.49M
327442 2023 2024-11-06 Cjbs LLC $4.17M
17594 2022 2022-12-01 Cjbs LLC $2.63M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
370624 2024 2025-10-09 1160229 2024-001 Material Weakness Yes P
370624 2024 2025-10-09 1160228 2024-001 Material Weakness Yes P
370624 2024 2025-10-09 1160227 2024-001 Material Weakness Yes P
370624 2024 2025-10-09 1160226 2024-001 Material Weakness Yes P
370624 2024 2025-10-09 1160225 2024-001 Material Weakness Yes P
370624 2024 2025-10-09 1160224 2024-001 Material Weakness Yes P
370624 2024 2025-10-09 1160223 2024-001 Material Weakness Yes P
339073 2024 2025-01-21 1096281 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 1096280 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 1096279 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 1096278 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 1096277 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 1096276 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 1096275 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519839 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519838 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519837 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519836 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519835 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519834 2024-001 Significant Deficiency - P
339073 2024 2025-01-21 519833 2024-001 Significant Deficiency - P